1. Home
  2. UNCY vs VTSI Comparison

UNCY vs VTSI Comparison

Compare UNCY & VTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UNCY
  • VTSI
  • Stock Information
  • Founded
  • UNCY 2016
  • VTSI 1993
  • Country
  • UNCY United States
  • VTSI United States
  • Employees
  • UNCY N/A
  • VTSI N/A
  • Industry
  • UNCY Biotechnology: Pharmaceutical Preparations
  • VTSI Miscellaneous manufacturing industries
  • Sector
  • UNCY Health Care
  • VTSI Consumer Discretionary
  • Exchange
  • UNCY Nasdaq
  • VTSI Nasdaq
  • Market Cap
  • UNCY 70.3M
  • VTSI 75.9M
  • IPO Year
  • UNCY 2021
  • VTSI N/A
  • Fundamental
  • Price
  • UNCY $0.62
  • VTSI $6.83
  • Analyst Decision
  • UNCY Strong Buy
  • VTSI Strong Buy
  • Analyst Count
  • UNCY 4
  • VTSI 2
  • Target Price
  • UNCY $5.50
  • VTSI $14.50
  • AVG Volume (30 Days)
  • UNCY 1.3M
  • VTSI 57.4K
  • Earning Date
  • UNCY 11-13-2024
  • VTSI 11-12-2024
  • Dividend Yield
  • UNCY N/A
  • VTSI N/A
  • EPS Growth
  • UNCY N/A
  • VTSI N/A
  • EPS
  • UNCY N/A
  • VTSI 0.53
  • Revenue
  • UNCY N/A
  • VTSI $31,771,647.00
  • Revenue This Year
  • UNCY N/A
  • VTSI N/A
  • Revenue Next Year
  • UNCY N/A
  • VTSI $24.06
  • P/E Ratio
  • UNCY N/A
  • VTSI $12.97
  • Revenue Growth
  • UNCY N/A
  • VTSI N/A
  • 52 Week Low
  • UNCY $0.20
  • VTSI $5.63
  • 52 Week High
  • UNCY $1.82
  • VTSI $17.68
  • Technical
  • Relative Strength Index (RSI)
  • UNCY 40.04
  • VTSI 50.45
  • Support Level
  • UNCY $0.61
  • VTSI $6.31
  • Resistance Level
  • UNCY $0.73
  • VTSI $7.01
  • Average True Range (ATR)
  • UNCY 0.07
  • VTSI 0.27
  • MACD
  • UNCY -0.02
  • VTSI 0.02
  • Stochastic Oscillator
  • UNCY 15.66
  • VTSI 56.02

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company includes installation, training, limited warranties, service agreements and related support. The company sells and supports use of force training and marksmanship firearms training systems and accessories for law enforcement, military or civilian use. The product line of the company includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire and other accessories.

Share on Social Networks: